Navigation Links
New Journal to Explore Neurodegenerative, Neuroprotective and Euroregenerative Therapies!
Date:10/2/2008

WESTON, Mass., Oct. 2 /PRNewswire/ -- Weston Medical Publishing today announced publication of the first issue of Journal of Neurodegeneration and Regeneration. (ISSN 1932-1481) This new peer-reviewed journal is designed to explore all aspects of neurodegeneration, neuroprotection and neuroregeneration including the molecular mechanisms, experimental approaches and their relevance in treating neurodegenerative disorders and neuroregenerative therapies.

When making the announcement, Publisher, Richard A. DeVito Jr. pointed out that while diagnosis may be the first step on the road of long term care for neurodegenerative patients, the pot of gold at the end of this difficult road will come from the challenging new frontier of neuroprotection and neuroregeneration research.

With the introduction of Journal of Neurodegeneration and Regeneration, (available online free of charge at http://ejournal.neuroregen.com until October 15th, 2008), the top neurospecialists worldwide will meet this challenge and bring to the medical community a long awaited exploration of the on-going research being conducted in this critical field.

Said DeVito, "The element of urgency couldn't be clearer. The numbers speak for themselves. In the United States alone, almost five million suffer from Alzheimer's disease; one million from Parkinson's disease; 400,000 from multiple sclerosis; and 30,000 from ALS. Worldwide, these four diseases account for more than 20 million patients."

"Further," he went on to say, "It is generally accepted that things are going to get worse before they get better. Aging greatly increases the risk of neurodegenerative disease and the average age of Americans and the worldwide populations are increasing. Today, over 37 million Americans alone are over the age of 65. Within the next 30 years this number is likely to double, putting more and more people at increased risk of neurodegenerative diseases."

"Research," DeVito noted, "will lead to better diagnosis, more effective treatments and, perhaps, cures for diseases like Alzheimer's, Parkinson's, multiple sclerosis, ALS and other diseases where few effective treatments and no cures are currently available."

The Journal of Neurodegeneration and Regeneration is guided by an international editorial review board of the foremost experts in the field under the leadership of co-Editors-in-Chief Dr. Philippe Taupin, PhD and Dr. Cathy Helgason, MD.

For manuscript submission or subscription information, visit the journal's Web page at http://www.neuroregen.com or contact the publisher, Weston Medical Publishing LLC, at 781-899-2702.

Contact: Richard A. DeVito, Jr.

Weston Medical Publishing

781-899-2702

radjr@pnpco.com


'/>"/>
SOURCE Weston Medical Publishing
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. News briefs from the journal Chest, August 2007
2. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
3. Elsevier launches new journal: Stem Cell Research
4. Elsevier announces new journal on inflammatory bowel diseases
5. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
6. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
7. Good Clinical Practice Journal Awards: Winners Announced
8. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
9. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
10. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
11. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/25/2016)... ... , ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter ... bar too high can result in disappointment, perhaps even self-loathing. However, those who set ... , Research from PsychTests.com reveals that behind the tendency to set low ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- In a startling report released today, National Safety Council ... comprehensive, proven plan to eliminate prescription opioid overdoses. Prescription ... are tackling the worst drug crisis in recorded U.S. history, assigned ... Kentucky , New Mexico , ... 28 failing states, three – Michigan , ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
Breaking Medicine Technology: